Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Connecticut Business Herald.
Press releases published on August 25, 2025

Compliant, Verified, and Ready: AED SERVICE AMERICA Protects AED Deployments Nationwide
Ensure your AEDs will work when needed. WINDSOR LOCKS, CT, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- Why a Qualified, Onsite AED Service Plan is Critical for True AED Readiness When lives are on the line, AED readiness cannot be left to …

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing significant unmet need Upfront cash payment of $5.35 per …

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer
US$2,054,651 non-dilutive grant from the US National Cancer Institute to complete manufacturing of Bria-Pros+TM clinical supply and support Phase 1/2a trial in metastatic prostate cancer Expands Bria-OTS+ novel personalized off-the-shelf immunotherapy …

Rising Demand in Electronics to Drive Data Converter Market to $7.4 Billion by 2028
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The report "Data Converter Market by Type (Analog-to-Digital Converters, Digital-to-Analog Converters), Sampling Rate (High-Speed Data Converters, General-Purpose Data Converters), Application and Region …
![[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/images/pressrelease-small.png)
[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Targeted Drug Delivery Market Size, Trends and Insights By Technology (Nanoparticle-Based Drug Delivery, Ligand-Based Targeting Systems, …

BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025
PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire oral presentation on …

Spectral Medical Receives US$3 Million From Vantive
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has received the US$3 million …

Humanoid Global Announces CEO Transition
Vancouver, BC, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) announced today changes to its management. Shahab Samimi will serve as the Chief Executive Officer of the …

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
Positive Results from MAPLE-HCM to be Shared in Hot Line Presentation Late Breaking Clinical Science Session to Present Incidence and Impact of Atrial Fibrillation Across Three Clinical Trials of Aficamten in Obstructive Hypertrophic Cardiomyopathy Company …

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing significant unmet need Upfront cash payment of $5.35 per …

Propanc Biopharma Provides Shareholder Update
MELBOURNE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …

FUNDAMENTAL GLOBAL INC. ACCELERATES TOTAL ETH HOLDINGS TO 48,545
Recent Purchases include 1,111 ETH at an Average Price of $4,341 Charlotte, NC, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fundamental Global Inc (Nasdaq: FGNX, FGNXP) (the “Company” or “FG Nexus”), today announced its current ETH position increased to 48,545 ETH …

Bitcoin Swift Confirms Early Launch on August 30 as Stage 6 Presale Surges Past $1 Million
LUXEMBOURG, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3) has confirmed an early launch date of August 30, 2025, following rapid fundraising momentum in its ongoing presale. The project, currently in Stage 6, has surpassed $1,000,000 in funds …

IREN Purchases 4.2k NVIDIA Blackwell GPUs & Secures Financing - AI Cloud Expanded to 8.5k GPUs
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced it has procured an additional 4.2k NVIDIA Blackwell B200 GPUs, which doubles IREN’s total GPU fleet to approximately 8.5k NVIDIA GPUs. In addition, IREN has …

New Report Reveals 85% of Health Plans Have Yet to Centralize Their Data Across Systems
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Arcadia® (arcadia.io), a leading healthcare data platform, today announced the publication of its latest research report, Scaling Smarter: The Data Strategies Powering High-Performing Health Plans. The report …

Synaptics To Participate at Upcoming Investor Conferences on Thursday, August 28, 2025 and Thursday, September 4, 2025
SAN JOSE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in upcoming investor conferences. Ken Rizvi, CFO, will participate at the Deutsche Bank’s Technology Conference on Thursday, August …

NuVista Energy Ltd. Confirms 2025 Production Guidance
CALGARY, Alberta, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NuVista Energy Ltd. (TSX:NVA, "NVA" or "NuVista") is pleased to confirm our annual average production guidance for 2025 of approximately 83,000 Boe/d (1). Despite continued delays in commissioning the …

Industry Leader David Stetson Joins Electra Board of Directors
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) is pleased to announce the appointment of David Stetson to its Board of Directors. Mr. Stetson is a seasoned executive …

Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …

JPMorgan Announces Cash Distributions for the JPMorgan ETFs
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- J. P. Morgan Asset Management (JPMAM)* today announced the final August 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of …